GILEAD SCIENCES INC. news, videos and press releases
For more news please use our advanced search feature.
GILEAD SCIENCES INC. - More news...
GILEAD SCIENCES INC. - More news...
- Gilead Sciences Publishes 2023 ESG Impact Report
- Gilead Sciences Champions Equal Pay
- Winn Awards Help Physicians Solve Healthcare Disparities
- Gilead Helps Launch Türkiye’s First HIV Testing Week
- Gilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations
- Gilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing
- Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
- Gilead Sciences: National Black HIV/AIDS Awareness Day
- Gilead Announces Funding Initiative To Support HIV Prevention, Anti-Stigma and Health Equity Efforts for Black Cisgender and Transgender Women and Girls in the U.S.
- Gilead Sciences and Black HIV/AIDS Awareness Day: Taking Action Toward Meaningful Change
- Gilead Named One of America’s Most JUST Companies by JUST Capital and CNBC
- Gilead Sets Sights on Hepatitis C Elimination As It Marks 10 Years of Curative Therapies
- Gilead Named One of Newsweek America’s Greatest Workplaces for Diversity
- From the Margins: Gilead’s Book Uniquely Captures What It’s Like To Be Marginalized by Disease
- Gilead Sciences: Art Captures the Experiences of Women Living With Metastatic Breast Cancer
- Gilead Sciences with Emma's Story: Self-Advocacy in Breast Cancer
- Gilead Pays Tribute to Patient Advocacy Work: Cara’s Story
- Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year
- Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program
- Gilead Supports World Health Organization To Bolster Public Health in Bangladesh
- Gilead's Legal Team Achieves Rigorous Diversity Certification
- Gilead's Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
- IDEAYA Announces Clinical Study Collaboration with Gilead Sciences to Evaluate Trodelvy® and IDE397 Combination in MTAP-Deletion Bladder Cancer
- Gilead Employees Stitch Together To Create a Special Panel of the AIDS Quilt
- GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC
- Gilead's Ambition: To Help End the HIV Epidemic
- Gilead Sciences: Breaking Barriers to Breast Cancer Care in Rural Areas
- Gilead Named Number One Overall Philanthropic Funder of HIV-Related Programs for Second Year in a Row by Funders Concerned About AIDS
- Gilead Sciences: Research Scholars Program Scientists Advancing HIV Research
- Gilead Sciences: Advancing Global Health Equity in Tropical Regions
